Report for the investigation of chinese medical and pharmaceutical CRO market (2008)

Publication Date	November 2008
Publisher	Beijing Inforce Cons.
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	CCM00219

Buy this product or for assistance call +44 20 7060 7474

PDF £900.00$1497 | €1007

FAX Order above formats by FAX

Summary

The report begins with the highlighted research factors : the rapid development of CRO service, the successful listing of PharmaTech in America, the bright prospect of China's CRO market. Meanwhile the history and development together with the service range are briefly illuminated.

The report profiles the research foundation of global medical industry together with the scale and prospect of global CRO service. It also combines the business structure with trends of global CRO service to analyze on CRO market in main districts and global leading CRO enterprises. Domestic competitive CRO enterprises are also presented in this report.

Please Note: Due to the Nature of This Report the Number of Pages is Unavailable

Content

The Research Foundation Of Cro
- 1.The Definition Of Cro Industry
- 2.The Emergence Of Cro
- 3.The Service Range Of Cro
Chapter One The Analysis Of Global Cro Industry Market
- Section I The Analysis Of The Development Of Cro Industry
  - 1.The Sales Scale Of Global Pharmaceutical Market (2007-2008)
  - 2. Top Ten Of Global Enterprises Which Invest Into The Research And Development Of New Drugs (2005)
  - 3. Top Fifteen Of Global Enterprises Which Invest Into The Research And Development (2006-2007)
- Section Ii The Analysis Of The Scales Of Global Cro Markets
  - 1. The Analysis Of Global R & D Expenses On New Drugs (2007-2010)
  - 2. The Scale Of Global Cro Market (2007-2010)
  - 3. The Prospect Of Global R & D Outsourcing Of New Drugs
- Section Iii The Analysis Of Cro Market Structure In 2007
  - 1.The Analysis Of R & D Outsourcing Of New Drugs
  - 2.The Business Structure Of New Drugs R & D Outsourcing
  - 3.The Characteristics Of The Business Structure Of New Drugs R & D Outsourcing Service
- Section Iv The Analysis Of Cro Local Market In 2007
  - 1. The Structure Of Global Cro Market
  - 2. The Analysis Of American Cro Industy
  - 3. The Analysis Of Indian Cro Market
  - 4. The Analysis Of Cro Market In Taiwan
- Section V The Structure Of The Competition Between Cro Enterprises In 2007
  - 1. The Analysis Of Global Cro Enterprises
  - 2. The Scan Of The World's Top Cro Companies
Chapter Two The Analysis Of Chnese Cro Market
- Section I The Analysis Of The Development Of Chnese Cro
  - 1.The Development Of Cro In China
  - 2.The Prospects Of Cro In China
- Section Ii The Analysis Of Domestic Cro Market
  - 1. Chinese Cro Market Between 2004 And 2007
  - 2.The Analysis Of The Business Structure Of Domestic Enterprises
- Section Iii The Competition Structure Of Domestic Cro Market
  - 1.The Types Of The Characteristics Of Domestic Cro Enterprises
  - 2.The Types Of The Business Of Domestic Cro Enterprises
  - 3. The Domestic Cro Companies
  - 4. Zhongguancun Biomedical R & D Outsourcing Union (Cro)
  - 5.The Biomedical R & D Outsourcing Center In Shanghai Pudong New Area
- Section V The Latest Trends Of The Industry Between 2007 And 2008
  - 1. Novamed Completes Financing The Second Round Of Venture Capital
  - 2. Sundia Completes Financing The Second Round Venture Capital In January Of 2008
  - 3. Novasecta Joins Chinese Pharmaceutical R & D Outsourcing Company Union For The First Time
Chapter Three The Analysis Of Domestic Key Enterprises
- Section I Pharma Tech
  - 1.The Introduction Of The Enterprise
  - 2.The Swot Analysis Of Competitiveness
  - 3.The Analysis Of The Financial Operation In 2007
- Section Ii The Analysis Of Other Enterprises
  - 1.Shanghai Chempartner Co. Ltd.
  - 2.Sandia Medical Technology (Shanghai)
  - 3.Beijing Mds
  - 4.Beijing Kendlewits Medicine
  - 5. Beijing Excel Medical Technology Development Co. Ltd.
  - 6. Beijing Venturepharm Technology Co., Ltd.
  - 7. Guangzhou Bo Ji State New Drugs Clinical Research Center
  - 8. Pharmaron (Beijing) New Drugs Technology Co., Ltd.
Notice
Index Of Charts
- Table 1 Top Ten Of Global Enterprises Which Invest Into R & D Of New Drugs (2005)
- Table 2 The Trend Of Global Enterprises Which Invest Into R & D (2006-2007)
- Table 3 The Market Growth Of Cro Of Global Pharmaceutical Industries (Unit: 100 Million U.S. Dollars)
- Table 4 The Global Cro Market Share (Unit: 100 Million U.S. Dollars; %)
- Table 5 The Sales Volume Of Globally Key Cro Enterprises In 2007
- Table 6 Main Global Cro Institutes And Their Business Directions
- Table 7 The List Of Part Of Domestic Cro Enterprises
- Table 8 Sponsors Of Zhongguancun Biomedical R & D Outsourcing Union (All In Random Order)
- Table 9 Part Of Enterprises Engaging In Biomedical R & D Outsourcing Service In Shanghai Pudong New Area
- Table 10 The Swot Analysis Of Pharmatech
- Table 11 The Projects Completed By Vps
- Table 12 The Projects Which Are Being Operated By Vps
- Figure 1 The Trend Of The Global Cro Market (2007-2010)
- Figure 2 The Scale Map Of The Outsourcing Market Value Of New Drugs R & D In 2007
- Figure 3 The Scale Map Of The Outsourcing Market Value Of New Drugs R & D
- Figure 4 The Market Share Of Global Leading International Cro Sectors (2001)
- Figure 5 The Trend Of Chinese Cro Market Between 2004 And 2007(Unit: Hundred Million Yuan)
- Figure 6 The Revenue Change Of (Unit: Million Dollars)
- Figure 7 The Regional Ratio Of The Revenue Of Mds Pharma Research Co. In 2007
- Figure 8 The Ratio Of The Revenue Of Mds Pharma Research Co. In Terms Of Different Customes In 2007
- Figure 9 The Ratio Of The Revenue Of Mds Pharma Research Co. In Terms Of Different Business Structures In 2007